Research output per year
Research output per year
Fingerprint
Dive into the research topics where Sonja Zweegman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Balancing Efficacy and Safety in Multiple Myeloma Patients Receiving B cell Maturation Antigen–Directed CAR T-Cell Therapy
Kuipers, M. T., Migchelbrink, J., Kramer, A. M., Kouwenhoven, M. C. M., Zweegman, S., Groen, K. & van de Donk, N. W. C. J., Jul 2026, In: BioDrugs. 40, 4, p. 607-621 15 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
BLOOD-BASED RISK STRATIFICATION OF MYELOMA PATIENTS USING CIRCULATING TUMOR CELLS: RESULTS FROM THE EUROPEAN CTC CONSORTIUM
Bertamini, L., Zihala, D., Kostopoulos, I. V., D'Agostino, M., Martin-Sanchez, E., Latre, J. J. G., Bruinink, D. H. O., Puig, N., Zweegman, S., Bertuglia, G., Malandrakis, P., Sevcikova, T., Cupedo, T., van de Donk, N. W. C. J., Cedena, M. T., Musto, P., Ntanasis-Stathopoulos, I., Venglar, O., van Duin, M. & Lahuerta, J. J. & 27 others, , 15 Apr 2026, In: Haematologica. 111, B04.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure) -
CIRCULATING TUMOR CELLS IMPROVE RISK STRATIFICATION ACCORDING TO THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM AND THE IMS-IMWG CONSENSUS GENOMIC STAGING IN NDMM PATIENTS. AN ANALYSIS FROM THE EUROPEAN CTC CONSORTIUM
D’Agostino, M., Martín-Sánchez, E., Žihala, D., Kostopoulos, I., Garcés, J. J., Puig, N., Bertuglia, G., Ševčíková, T., Cupedo, T., van Duin, M., Keats, J., Zamagni, E., Moreau, P., Zweegman, S., van der Holt, B., Hofste op Bruinink, D., Dama, E., Corre, J., Boccadoro, M. & Dimopoulos, M. A. & 9 others, , 2026, In: Haematologica. 111, 2, p. 1-2 2 p., P01.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure) -
Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE
Bahlis, N., Facon, T., San-Miguel, J., Usmani, S. Z., Dimopoulos, M. A., Moreau, P., Zweegman, S., Perrot, A., Manier, S., Chari, A., Raje, N., Orlowski, R. Z., Goldschmidt, H., Basu, S., Hulin, C., Weisel, K., Mohty, M., Leleu, X., Plesner, T. & Jakubowiak, A. & 10 others, , 14 Jul 2026, In: Blood. 10, 13, p. 4541-4550 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients
van de Donk, N. W. C. J., Schjesvold, F., van der Holt, B., Minnema, M. C., Wu, K. L., Broijl, A., Roeloffzen, W. W. H., Gadisseur, A., Pietrantuono, G., Pour, L., van der Velden, V. H. J., Lund, T., Offidani, M., Bringhen, S., Giaccone, L., Razawy, W., Tacchetti, P., Mancuso, K., Silkjaer, T. & Caers, J. & 8 others, , 1 Dec 2026, In: Blood cancer journal. 16, 1, 102.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access
Press/Media
-
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera
01/03/2025
1 Media contribution
Press/Media: other
-
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial
01/02/2025
1 Media contribution
Press/Media: other